Drugmaker, Human Genome Sciences | featured news

Welcome to Wopular's coverage of Drugmaker, Human Genome Sciences. Wopular aggregates news headlines from the top newspapers and news sources. To the right are articles about Drugmaker, Human Genome Sciences that have been featured on main sections of the site.

Below are topics about Drugmaker, Human Genome Sciences. (Click on "all" to view all articles related to the topic, including articles NOT about Drugmaker, Human Genome Sciences.

Click here to search news sites, aggregators, and blogs as well as videos, photos, and websites about Drugmaker, Human Genome Sciences.

Bookmark or Share

Main Topics

Drugmaker Topics

Exclusive: GSK set for Human Genome takeover

GlaxoSmithKline is expected to announce a deal to buy Human Genome Sciences for about $2.8 billion as soon as Monday, ending a three-month hostile pursuit of the U.S. biotech company on friendly terms after sweetening its offer.

Exclusive: GSK eyes replacing Human Genome board

GlaxoSmithKline Plc plans to launch a campaign to replace the entire board of Human Genome Sciences Inc with its own nominees, stepping up its $2.6 billion hostile bid for the U.S. biotech company, sources familiar with the situation said on Wednesday.

GlaxoSmithKline appeals directly to Human Genome Sciences shareholders in buyout dispute

British drugmaker GlaxoSmithKline said Wednesday it will no longer wait for Human Genome Sciences to consider an acquisition offer and instead appealed directly to the Rockville firm’s shareholders to accept its $13-per-share asking price.

Subscribe to this RSS topic: